Synthesis, Biological Activity Evaluation, Docking and Molecular Dynamics Studies of New Triazole‐Tetrahydropyrimidinone(thione) Hybrid Scaffolds as Urease Inhibitors
Chemistry & Biodiversity · 2023
DOI: 10.1002/cbdv.202300054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Sadaf Rezvanpoor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical Sciences, 56189-53141, Ardabil, Iran. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Urease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Ardabil University of Medical Sciences.
Abstract (Originalsprache)
New series of triazole‐tetrahydropyrimidinone(thione) hybrids ( 9a – g ) were synthesized. FT‐IR, 1 H‐NMR, 13 C‐NMR, elemental analysis and mass spectroscopic studies characterized the structures of the synthesized compounds. Then, the synthesized compounds were screened to determine the urease inhibitory activity. Methyl 4‐(4‐((1‐(2‐chlorobenzyl)‐1H‐1,2,3‐triazol‐4‐yl)methoxy)phenyl)‐6‐methyl‐2‐thioxo‐1,2,3,4‐tetrahydropyrimidine‐5‐carboxylate ( 9c ) exhibited the highest urease inhibitory activity (IC 50 =25.02 μM) among the compounds which was almost similar to thiourea as standard (IC 50 =22.32 μM). The docking study of the screened compounds demonstrated that these compounds fit well in the urease active site. Based on the docking study, compound 9c with the highest urease inhibitory activity showed chelates with both Ni 2+ ions of the urease active site. Moreover, the molecular dynamic study of the most potent compounds showed that they created important interactions with the active site flap residues, His322, Cys321, and Met317.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical Sciences, 56189-53141, Ardabil, Iran.
- Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, 9138813944, Mashhad, Iran.
- Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, 9138813944, Mashhad, Iran.
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, 81746-73461, Isfahan, Iran.
- Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, 56189-53141, Ardabil, Iran.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, 9138813944, Mashhad, Iran.
Förderung
- Ardabil University of Medical Sciences
Zitieren
APA
Rezvanpoor, S., Shakour, N., Ahangarzadeh, N., Bakherad, H., Sepehri, S., Farhadi, G., Hosein Pakdel, M., & Iranshahi, M. (2023). Synthesis, Biological Activity Evaluation, Docking and Molecular Dynamics Studies of New Triazole‐Tetrahydropyrimidinone(thione) Hybrid Scaffolds as Urease Inhibitors. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202300054
Vancouver
Rezvanpoor S, Shakour N, Ahangarzadeh N, Bakherad H, Sepehri S, Farhadi G, et al. Synthesis, Biological Activity Evaluation, Docking and Molecular Dynamics Studies of New Triazole‐Tetrahydropyrimidinone(thione) Hybrid Scaffolds as Urease Inhibitors. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202300054
BibTeX
@article{Rezvanpoor2023,
author = {Rezvanpoor, Sadaf and Shakour, Neda and Ahangarzadeh, Nazli and Bakherad, Hamid and Sepehri, Saghi and Farhadi, Ghazaleh and Hosein Pakdel, Mohammad and Iranshahi, Mehrdad},
title = {Synthesis, Biological Activity Evaluation, Docking and Molecular Dynamics Studies of New Triazole‐Tetrahydropyrimidinone(thione) Hybrid Scaffolds as Urease Inhibitors},
journal = {Chemistry & Biodiversity},
year = {2023},
doi = {10.1002/cbdv.202300054}
}
EUVIMED